Search
for
Sort by
Research 481–510 of 1000+
- Female hair concerns with age
- Frequency of Hirsutism among females students in Babol University of Medical Sciences, 1999
- PREFACE
- Clinical markers of hyperandrogenism and response to conventional antibiotic therapy in women with acne vulgaris
- Inhibitory activities of some traditional Chinese herbs against testosterone 5α-reductase and effects of Cacumen platycladi on hair re-growth in testosterone-treated mice
- Effect of<i>Cuscuta reflexa</i>Roxb on androgen-induced alopecia
- The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
- Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes
- A new label-free screen for steroid 5α-reductase inhibitors using LC-MS
- An inherited nail dystrophy principally affecting the great toenails
- Rotterdam criteria–based diagnostic subtype is not a strong predictor of cutaneous phenotype in patients with polycystic ovary syndrome: A cross-sectional study
- Treatment of Alopecia with New Approaches: An Updated Review
- Effects of Hair Loss on Depression in Generation MZ
- Beta 1 Integrin in Hair Follicles of Patients with Androgenetic Alopecia
- The anatomical distribution of lentiginous melanoma (lentigo maligna and lentigo maligna melanoma): Differences according to sex
- 32731 Alopecia in COVID-19 patients: Systematic review and meta-analysis
- HAIRFALL DUE TO AIR POLLUTION
- The Perfectionism-Psychological Outcome Link: The Mediating Effect of Personal Resiliency
- UP-03.25
- Drugs Affecting Hair Growth
- Fibrous scaffolds potentiate the paracrine function of mesenchymal stem cells: A new dimension in cell-material interaction
- Angiogenesis: a Dynamic Balance of Stimulators and Inhibitors
- DataSheet1.zip
- Regeneration of Dermis: Scarring and Cells Involved
- Alopecia and the metabolic syndrome
- THE PREVALENCE OF SKIN DISEASE IN THE GERIATRIC AGE GROUP
- Detectability of oxandrolone, metandienone, clostebol and dehydrochloromethyltestosterone in urine after transdermal application
- Metabolism and skin diseases
- Spironolactone May Reduce the Risk of Incident Rosacea
- Serum C-19 steroid sulphates in females with clinical hyperandrogenism